Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hansen

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 27, 2018
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 DiabetesChantal Mathieu, Doina Catrinoiu, Aurelian Emil Ranetti, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2017
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialParesh Dandona, Chantal Mathieu, Moshe Phillip, et al.
Diabetes|January 30, 2010
Combined analyses of 20 common obesity susceptibility variantsCamilla Helene Sandholt, Thomas Sparsø, Niels Grarup, et al.
Clinical Biochemistry|August 11, 2004
A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjectsEva-Maria D Nielsen, Lars Hansen, Maria Lajer, et al.
Case Reports in Genetics|October 18, 2012
Intrafamilial Variability of Early-Onset Diabetes due to an INS MutationSiri Fredheim, Jannet Svensson, Sven Pørksen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approachHongtao Yu, Sebastian Ueckert, Lina Zhou, et al.
Biochemical and Biophysical Research Communications|September 17, 2004
Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetesLars Hansen, Michael Gaster, Edward J Oakeley, et al.
European Journal of Human Genetics : EJHG|February 20, 2014
The myosin chaperone UNC45B is involved in lens development and autosomal dominant juvenile cataractLars Hansen, Sophie Comyn, Yuan Mang, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2005
Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traitsEva-Maria D Nielsen, Lars Hansen, Trine Stissing, et al.
Pharmacogenetics|July 2, 2003
Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjectsEva-Maria D Nielsen, Lars Hansen, Søren M Echwald, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 27, 2018
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 DiabetesChantal Mathieu, Doina Catrinoiu, Aurelian Emil Ranetti, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2017
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialParesh Dandona, Chantal Mathieu, Moshe Phillip, et al.
Diabetes|January 30, 2010
Combined analyses of 20 common obesity susceptibility variantsCamilla Helene Sandholt, Thomas Sparsø, Niels Grarup, et al.
Clinical Biochemistry|August 11, 2004
A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjectsEva-Maria D Nielsen, Lars Hansen, Maria Lajer, et al.
Case Reports in Genetics|October 18, 2012
Intrafamilial Variability of Early-Onset Diabetes due to an INS MutationSiri Fredheim, Jannet Svensson, Sven Pørksen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approachHongtao Yu, Sebastian Ueckert, Lina Zhou, et al.
Biochemical and Biophysical Research Communications|September 17, 2004
Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetesLars Hansen, Michael Gaster, Edward J Oakeley, et al.
European Journal of Human Genetics : EJHG|February 20, 2014
The myosin chaperone UNC45B is involved in lens development and autosomal dominant juvenile cataractLars Hansen, Sophie Comyn, Yuan Mang, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2005
Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traitsEva-Maria D Nielsen, Lars Hansen, Trine Stissing, et al.
Pharmacogenetics|July 2, 2003
Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjectsEva-Maria D Nielsen, Lars Hansen, Søren M Echwald, et al.
Pageof 18